ConductScience.org, home

Paper41998209

Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity.

Hong S and 5 others. Oncogene, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity. Papers, record 41998209. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998209

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity.
PubMed
Journal
Oncogene
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hong SSeyeon
2Lee SGSung-Gwon
3Lee DDogeun
4Kim JJihyeon
5Song MMiryoung
6Lim DDaejinhttps://orcid.org/0000-0003-0375-1857

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Escherichia coliMajor topic
Promoter Regions, GeneticMajor topic
ImmunotoxinsMajor topic
Escherichia coli ProteinsMajor topic
Animals
Mice
Bacterial Toxins
Exotoxins
Pseudomonas aeruginosa Exotoxin A
Cell Line, Tumor
Humans
Transforming Growth Factor alpha
ADP Ribose Transferases

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
NRF-RS-2023-00210053National Research Foundation of Korea (NRF)NRFRS202300PubMedNIH RePORTER
NRF-RS-2025-02263715National Research Foundation of Korea (NRF)NRFRS202502PubMedNIH RePORTER
2019M3E5D5066666National Research Foundation of Korea (NRF)PubMedPubMed
2022M3E5F1018375National Research Foundation of Korea (NRF)PubMedPubMed
2025Hankuk University of Foreign Studies (HUFS)PubMedPubMed

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123964706Tumor-colonizing bacteria: a potential tumor targeting therapy.Crit Rev Microbiol2014https://conductscience.org/library/papers/23964706PubMed
240528960Engineered bacteria: Strategies and applications in cancer immunotherapy.Fundam Res2025https://conductscience.org/library/papers/40528960PubMed
32129426Selective killing of tumor cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules.Semin Cancer Biol1990https://conductscience.org/library/papers/2129426PubMed
434326488Enhancing the tropism of bacteria via genetically programmed biosensors.Nat Biomed Eng2022https://conductscience.org/library/papers/34326488PubMed
537509078Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment.Biomolecules2023https://conductscience.org/library/papers/37509078PubMed
68313355Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.Cancer Res1994https://conductscience.org/library/papers/8313355PubMed
739502977Microbial Therapeutics in Oncology: A Comprehensive Review of Bacterial Role in Cancer Treatment.Cureus2024https://conductscience.org/library/papers/39502977PubMed
828286304Regulation of hypoxia-inducible gene expression after HIF activation.Exp Cell Res2017https://conductscience.org/library/papers/28286304PubMed
930278129Modular Pore-Forming Immunotoxins with Caged Cytotoxicity Tailored by Directed Evolution.ACS Chem Biol2018https://conductscience.org/library/papers/30278129PubMed
108339264Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.Cancer Res1993https://conductscience.org/library/papers/8339264PubMed
1138053546Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum.Mol Ther Oncolytics2023https://conductscience.org/library/papers/38053546PubMed
1237201582Spatiotemporal regulation of the BarA/UvrY two-component signaling system.J Biol Chem2023https://conductscience.org/library/papers/37201582PubMed
1337906273Effects of Chemotherapy on the Immune System: Implications for Cancer Treatment and Patient Outcomes.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/37906273PubMed
1436900277Constitutive Expression of a Cytotoxic Anticancer Protein in Tumor-Colonizing Bacteria.Cancers (Basel)2023https://conductscience.org/library/papers/36900277PubMed
1536123348Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.Signal Transduct Target Ther2022https://conductscience.org/library/papers/36123348PubMed
1620436464Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.Nat Biotechnol2010https://conductscience.org/library/papers/20436464PubMed
1735151278The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.BMC Microbiol2022https://conductscience.org/library/papers/35151278PubMed
1831160120Acetate Metabolism in Physiology, Cancer, and Beyond.Trends Cell Biol2019https://conductscience.org/library/papers/31160120PubMed
1935681100Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors.Nat Cancer2022https://conductscience.org/library/papers/35681100PubMed
2025853312Potent and tumor specific: arming bacteria with therapeutic proteins.Ther Deliv2015https://conductscience.org/library/papers/25853312PubMed

See all 57 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42415153From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine.J Hematol Oncol2026https://conductscience.org/library/papers/42415153

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41998209

GET https://conductscience.org/api/papers/v1/41998209/references?page=2